AAPL 186.61 +0.12 (+0.06%)MSFT 126.9 +0.03 (+0.02%)FB 184.76 +0.03 (+0.02%)ZNGA 6.17 0 (+0.08%)NVDA 155.05 -0.2 (-0.13%)WBA 52.73 +0.06 (+0.11%)GOOG 1148.79 -1.09 (-0.09%)PIH 5.7 -0.12 (-2.06%)
AAPL 186.61 +0.12 (+0.06%)MSFT 126.9 +0.03 (+0.02%)FB 184.76 +0.03 (+0.02%)ZNGA 6.17 0 (+0.08%)NVDA 155.05 -0.2 (-0.13%)WBA 52.73 +0.06 (+0.11%)GOOG 1148.79 -1.09 (-0.09%)PIH 5.7 -0.12 (-2.06%)

Financial Summary ABT Quote Abbott Labo

Abbott Laboratories Quote

Abbott Laborato (ABT)

76.04 -0.26 Healthcare
Stock Performance rating :
Recommendation :
Not Available
Symbol ABT
Price 76.04
Beta 1.12
Vol Avg 6.52 M
Mkt cap 137.02 B
Shares 1.48 K
Last Div 1.28
Div Yield 1.36%
DCF Unlevered Not Available Not Available
DCF Levered Not Available Not Available
ROE Not Available Not Available
ROA Not Available Not Available
Operating Margin Not Available Not Available
Debt/Equity Not Available Not Available
P/E Not Available Not Available
P/B Not Available Not Available
All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Income Statement
Year 20142015201620172018
Revenue 20,247 20,405 20,853 0 0
COGS 9,218 8,747 9,024 12,337 12,706
GrossProfit 11,029 11,658 11,829 15,053 17,872
Depreciation (included in COGS) 1,548 1,472 1,353 0 0
StockBasedCompe (included in COGS) 246 292 310 406 477
ResearchAndDeve 1,345 1,405 1,422 2,235 2,300
SalesGeneralAnd 6,530 6,785 6,672 9,117 9,744
OperatingIncome 2,599 2,867 3,185 1,726 3,650
InterestExpense 150 163 431 904 826
OtherIncome 69 479 -1,341 1,409 49
IncomeBeforeTax 2,518 3,183 1,413 2,231 2,873
ProvisionForInc 0 0 0 0 0
NetIncome 2,284 4,423 1,400 477 2,368
Balance Sheet
Year 20142015201620172018
CashAndCashEqui 4,063 5,001 18,620 9,407 3,844
ShortTermInvest 397 1,124 155 203 242
Cash 4,460 6,125 18,775 0 0
AccountReceivab 3,586 3,418 3,248 0 0
Inventories 2,643 2,599 2,434 0 0
DeferredIncomeT 1,651 2,119 2,263 1,944 1,868
OtherCurrentAss 892 105 513 20 9
TotalCurrentAss 15,261 14,155 26,776 20,147 14,632
PPE 12,632 12,383 12,366 15,265 15,706
AccumulatedDepr -6,697 -6,653 -6,661 -7,658 -8,143
NetPPE 5,935 5,730 5,705 7,607 7,563
EquityAndOtherI 229 4,041 2,947 883 897
Goodwill 10,067 9,638 7,683 24,020 23,254
IntangibleAsset 6,198 5,562 4,539 21,473 18,942
OtherLTAssets 1,934 2 2,753 176 17
TotalNonCurrent 26,014 27,092 25,890 56,103 52,541
TotalAssets 41,275 41,247 52,666 76,250 67,173
ShortTermDebt 4,437 3,130 1,325 714 207
AccountsPayable 1,064 1,081 1,178 0 0
TaxesPayable 270 430 188 309 305
AccruedLiabilit 3,631 3,649 3,223 0 0
DeferredRevenue 0 0 0 0 0
OtherCurrentLia 1,130 896 746 613 729
TotalCurrentLia 10,532 9,186 6,660 8,912 9,012
Debt 3,408 5,871 20,681 0 0
DeferredTaxesLi 860 808 356 2,006 2,056
DeferredRevenue 0 0 0 0 0
OtherLTLiabilit 1,961 1,815 2,098 4,855 3,984
TotalNonCurrent 9,217 10,850 25,468 36,441 27,637
TotalLiabilitie 19,749 20,036 32,128 45,353 36,649
CommonStock 0 0 0 0 0
AdditionalPaidI 12,383 12,734 13,027 23,206 23,512
RetainedEarning 22,874 25,757 25,565 23,978 24,560
AccumulatedOthe -5,053 -6,658 -7,263 -6,062 -7,586
TotalStockholde 21,526 21,211 20,538 30,897 30,524
TotalLiabilitie 41,275 41,247 52,666 76,250 67,173
Cash Flow Statement
Year 20142015201620172018
NetIncome 2,284 4,423 1,400 477 2,368
Depreciation 1,548 1,472 1,353 0 0
DeferredIncomeT 0 0 0 0 0
StockBasedCompe 246 292 310 406 477
AccountsReceiva -195 -171 -177 -207 -190
InventoryCS -297 -257 -98 249 -514
AccountsPayable -225 -742 -652 615 747
OtherWorkingCap 0 0 0 0 0
OtherNonCashIte 87 -3,065 1,653 -249 325
NetCashProvided 3,675 2,966 3,203 5,570 6,300
InvestmentsInPP -1,077 -1,110 -1,121 -1,135 -1,394
AcquisitionsNet -3,317 2,285 -55 -8,437 48
PurchasesOfInve -1,507 -4,933 -2,823 -210 -131
SalesMaturities 5,624 4,112 3,709 129 73
PurchasesOfInta 0 0 0 0 0
OtherInvestingA 75 52 42 35 48
NetCashUsedForI -202 406 -248 -9,618 -1,356
DebtIssued 0 2,485 14,934 6,742 4,009
DebtRepayment -577 -57 -12 -8,650 -12,433
CommonStockIssu 0 0 0 0 0
CommonStockRepu -2,195 -2,237 -522 -117 -238
DividendPaid -1,342 -1,443 -1,539 -1,849 -1,974
OtherFinancingA 1,372 -984 -1,714 -697 245
NetCashProvided -2,742 -2,236 11,147 -5,281 -10,391
NetChangeInCash 588 938 13,619 -9,213 -5,563
CashAtBeginning 3,475 4,063 5,001 18,620 9,407
CashAtEndOfPeri 4,063 5,001 18,620 9,407 3,844
Retained Earnings
Year 20142015201620172018
RetainedEarning ---22,87425,757
NetIncome --2,2844,4231,400
StockDividend ---23,816-5,863331
DividendPaid ---1,342-1,443-1,539
RetainedEarning --22,87425,75725,565
Property Plant and Equipment Schedule
Year 20142015201620172018
NetPPE ---5,9355,730
DeprAnnual 0--6,69744-8
CapitalExpendit 00107711101121
NetPPE --5,9355,7305,705
Intangible and Goodwill Schedule
Year 20142015201620172018
intAndGW 0--16,26515,200
Amortization 0-5,149-1,516-1,345
NewPurchases 0-11,116451-1,633
intAndGW --16,26515,20012,222
Company Profile

CEO

Miles D. White

Sector

Healthcare

Industry

Drug Manufacturers

Exchange

New York Stock Exchange

Description

Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs.